VIR logo

Vir Biotechnology (VIR)

Profile

Full Name

Vir Biotechnology, Inc.

Ticker Symbol

VIR

Exchange

NASDAQ

Country

United States

IPO

October 11, 2019

Indexes

Not included

Employees

408

Key Details

Price

$6.00

Market Cap

$822.86M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$63.71M(+61.32% YoY)

Annual EPS

-$3.83(+16.56% YoY)

PE Ratio

-

Next earnings date

May 2, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Feb 28, 25 HC Wainwright & Co.
Buy
Feb 28, 25 Barclays
Overweight
Feb 27, 25 Needham
Buy
Jan 31, 25 HC Wainwright & Co.
Buy
Jan 13, 25 Leerink Partners
Outperform
Jan 10, 25 HC Wainwright & Co.
Buy
Jan 9, 25 Morgan Stanley
Overweight
Jan 9, 25 JP Morgan
Neutral
Nov 20, 24 Needham
Buy
Nov 20, 24 HC Wainwright & Co.
Buy

Institutional Ownership

  • What is the ticker symbol for Vir Biotechnology?
  • Does Vir Biotechnology pay dividends?
  • What sector is Vir Biotechnology in?
  • What industry is Vir Biotechnology in?
  • What country is Vir Biotechnology based in?
  • When did Vir Biotechnology go public?
  • Is Vir Biotechnology in the S&P 500?
  • Is Vir Biotechnology in the NASDAQ 100?
  • Is Vir Biotechnology in the Dow Jones?
  • When was Vir Biotechnology's last earnings report?
  • When does Vir Biotechnology report earnings?
  • Should I buy Vir Biotechnology stock now?

What is the ticker symbol for Vir Biotechnology?

The ticker symbol for Vir Biotechnology is NASDAQ:VIR

Does Vir Biotechnology pay dividends?

No, Vir Biotechnology does not pay dividends

What sector is Vir Biotechnology in?

Vir Biotechnology is in the Healthcare sector

What industry is Vir Biotechnology in?

Vir Biotechnology is in the Biotechnology industry

What country is Vir Biotechnology based in?

Vir Biotechnology is headquartered in United States

When did Vir Biotechnology go public?

Vir Biotechnology's initial public offering (IPO) was on October 11, 2019

Is Vir Biotechnology in the S&P 500?

No, Vir Biotechnology is not included in the S&P 500 index

Is Vir Biotechnology in the NASDAQ 100?

No, Vir Biotechnology is not included in the NASDAQ 100 index

Is Vir Biotechnology in the Dow Jones?

No, Vir Biotechnology is not included in the Dow Jones index

When was Vir Biotechnology's last earnings report?

Vir Biotechnology's most recent earnings report was on Feb 26, 2025

When does Vir Biotechnology report earnings?

The next expected earnings date for Vir Biotechnology is May 2, 2025

Should I buy Vir Biotechnology stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page